GeneDx Holdings Corp. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
GeneDx Holdings Corp. (WGS) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $12.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-03
- GeneDx Holdings Corp. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $0.00.
- GeneDx Holdings Corp. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $12.09M.
- GeneDx Holdings Corp. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-06-30 was $0.00.
- GeneDx Holdings Corp. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-03-31 was $0.00.
- GeneDx Holdings Corp. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $0.00.
- GeneDx Holdings Corp. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- GeneDx Holdings Corp. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $637.00K.
- GeneDx Holdings Corp. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $0.00.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $12.09M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $12.09M 10-Q · filed 2026-05-04 | ||
| 2025-12-31 | $0.00 10-K · filed 2026-02-23 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-04 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-02-23 | ||
| 2023-12-31 | $637.00K 10-K · filed 2026-02-23 | ||
| 2022-12-31 | $0.00 10-K · filed 2024-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |